ArticleJournal of the American Chemical Society2026
DNA Modulates Structural Transitions and Oligomerization Kinetics of the Functional Amyloid CRES.
Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Functional amyloids play critical roles in diverse physiological processes; however, the molecular mechanisms regulating their assembly remain unknown. The mouse epididymal lumen contains a functional amyloid- and nucleic acid-rich extracellular matrix with roles in host defense and sperm maturation. Cystatin-related epididymal spermatogenic (CRES), a reproductive cystatin and key component of the mammalian epididymal amyloid matrix, assembles into structurally heterogeneous amyloid forms to support the various roles of this extracellular matrix. Here, we show that CRES binds double-stranded DNA with submicromolar affinity in a sequence independent manner and that DNA binding accelerates amyloid formation by increasing local protein concentration and promoting specific oligomerization pathways. Using NMR spectroscopy, site-directed mutagenesis, and biophysical analyses, we find that DNA interacts primarily with the CRES loop region, thereby occluding one assembly mechanism and redirecting oligomerization through a pathway involving the L1 loop. These DNA-mediated changes in assembly kinetics and pathway selection suggest a regulatory mechanism for achieving structural and functional diversity in nonpathological amyloid systems. Our findings provide a molecular framework for understanding nucleic acid-guided amyloidogenesis and highlight how functional amyloids may exploit multiple assembly routes to fulfill their physiological roles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.